BI
BVF Inc’s Eledon Pharmaceuticals ELDN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $17.1M | Hold |
6,293,282
| – | – | 0.61% | 26 |
|
2025
Q1 | $21.3M | Hold |
6,293,282
| – | – | 0.87% | 22 |
|
2024
Q4 | $25.9M | Hold |
6,293,282
| – | – | 0.88% | 24 |
|
2024
Q3 | $15.7M | Hold |
6,293,282
| – | – | 0.46% | 31 |
|
2024
Q2 | $16.6M | Buy |
6,293,282
+1,966,572
| +45% | +$5.19M | 0.47% | 36 |
|
2024
Q1 | $8.91M | Hold |
4,326,710
| – | – | 0.25% | 41 |
|
2023
Q4 | $7.79M | Hold |
4,326,710
| – | – | 0.19% | 51 |
|
2023
Q3 | $5.93M | Hold |
4,326,710
| – | – | 0.16% | 53 |
|
2023
Q2 | $5.93M | Buy |
4,326,710
+2,000,000
| +86% | +$2.74M | 0.17% | 52 |
|
2023
Q1 | $5.49M | Hold |
2,326,710
| – | – | 0.2% | 57 |
|
2022
Q4 | $5.4M | Hold |
2,326,710
| – | – | 0.23% | 56 |
|
2022
Q3 | $6.42M | Hold |
2,326,710
| – | – | 0.27% | 57 |
|
2022
Q2 | $5.68M | Hold |
2,326,710
| – | – | 0.27% | 57 |
|
2022
Q1 | $9.17M | Buy |
2,326,710
+948,690
| +69% | +$3.74M | 0.37% | 57 |
|
2021
Q4 | $6.08M | Buy |
1,378,020
+14,585
| +1% | +$64.3K | 0.22% | 62 |
|
2021
Q3 | $8.43M | Buy |
1,363,435
+250,000
| +22% | +$1.54M | 0.33% | 57 |
|
2021
Q2 | $8.81M | Hold |
1,113,435
| – | – | 0.33% | 52 |
|
2021
Q1 | $11.9M | Buy |
1,113,435
+350,156
| +46% | +$3.75M | 0.45% | 45 |
|
2020
Q4 | $11.8M | Sell |
763,279
-2,752,594
| -78% | -$42.4M | 0.46% | 40 |
|
2020
Q3 | $3.34M | Buy |
3,515,873
+1,730,873
| +97% | +$1.64M | 0.18% | 57 |
|
2020
Q2 | $818K | Buy |
1,785,000
+1,100,187
| +161% | +$504K | 0.05% | 55 |
|
2020
Q1 | $267K | Sell |
684,813
-144,063
| -17% | -$56.2K | 0.02% | 57 |
|
2019
Q4 | $481K | Hold |
828,876
| – | – | 0.04% | 56 |
|
2019
Q3 | $522K | Hold |
828,876
| – | – | 0.05% | 59 |
|
2019
Q2 | $837K | Buy |
+828,876
| New | +$837K | 0.09% | 56 |
|